PDCD1 and melanoma: Melanoma patients that responded well to anti-PD-1 therapy had diverse bacteria with abundant Faecalibacterium, Bifidobacterium longum, and Bacteroidales, while the presence of Ruminococcus obeum and Roseburia intestinalis was associated with non-responsiveness.